WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Analysis: Larson enters conversation with Verstappen as best drivers in the world
Meghan Markle purchased pair of £1990 diamond earrings from Dragons' Den hopefuls
EPHRAIM HARDCASTLE: Could William and Harry be reunited at the Duke of Westminster's wedding?
CONTRIBUTIONS STANDARD TERMS AND CONDITIONS
Who is Jacob Zuma, the former South African president disqualified from next week's election?
Oscars 2024: The Biggest Moments from the 96th Academy Awards
OpenAI pauses ChatGPT voice after Scarlett Johansson comparisons
Time for some Royal R&R! King Charles and Queen Camilla arrive in Aberdeen for a restful
College baseball notebook: Conference tournaments to decide NCAA automatic bids and many at
Isla Phillips: The little royal and great